Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
25.04
-0.53 (-2.07%)
Nov 19, 2026, 4:00 PM EST - Market closed
Veracyte Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Veracyte stock has a consensus rating of "Buy" and an average price target of $41.6. The average 1-year stock price forecast is 66.13% higher than the current stock price, while the lowest is $30 (+19.81%) and the highest is $60 (+139.62%).
Price Target: $41.6 (+66.13%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Veracyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 8 | 9 | 9 | 7 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 11 | 11 | 12 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $65 → $35 | Buy | Reiterates | $65 → $35 | +39.78% | Nov 17, 2026 |
| Stephens | Stephens | Buy Reiterates $40 | Buy | Reiterates | $40 | +59.74% | Nov 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $54 → $30 | Buy | Reiterates | $54 → $30 | +19.81% | Nov 10, 2026 |
| UBS | UBS | Buy Reiterates $65 → $35 | Buy | Reiterates | $65 → $35 | +39.78% | Nov 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $50 | Hold | Reiterates | $50 | +99.68% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
590.78M
from 517.15M
Increased by 14.24%
Revenue Next Year
628.69M
from 590.78M
Increased by 6.42%
EPS This Year
1.94
from 1.78
Increased by 8.86%
EPS Next Year
1.56
from 1.94
Decreased by -19.72%
EPS and Forward PE are based on non-GAAP adjusted numbers.